Beeline flies into phase 3 as oral lupus drug soars past placebo Read more →

Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics Read more →

Solstice rises with $225M series A to advance next-gen CTLA-4 immunotherapy into phase 2 Read more →